. . . . . . . "[A new class of less-calcemic 1?,25(OH)2D3 analog, MART-10 (19-nor-2?-(3-hydroxypropyl)- 1?,25-Dihydroxyvitamin D3), has been shown to be much more potent than 1?,25(OH)2D3 in inhibiting cancer cell growth in vitro and in vivo without inducing hypercalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:30+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .